Accumulation of 111In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Co-administration of Targeting Ligand
The successful use of targeted radionuclide therapy in the treatment of solid tumours may be limited by radioresistance, which necessitates delivery of a high dose of radioactivity. Nanoparticle (NP)-based delivery systems possess a large surface area for attachment of radioisotopes and so offer a s...
Autores principales: | Song, L, Able, S, johnson, E, Vallis, KA |
---|---|
Formato: | Journal article |
Publicado: |
Ivyspring International Publisher
2017
|
Ejemplares similares
-
SPECT imaging and biodistribution studies of 111In-EGF-Au-PEG nanoparticles in vivo
por: Song, L, et al.
Publicado: (2016) -
111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
por: Reilly, R, et al.
Publicado: (2000) -
In-111-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR
por: Reilly, R, et al.
Publicado: (2000) -
A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
por: Reilly, R, et al.
Publicado: (2000) -
111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells
por: Gill, M, et al.
Publicado: (2018)